November 4, 2024
With the discovery of autoantibodies and other risk factors for rheumatoid arthritis (RA), researchers developed clinical trials to see whether the disease can be prevented entirely. […]
November 4, 2024
Many people with rheumatologic diseases try supplements for symptom relief. Here’s what you need to know about some common picks. Dietary supplements were a $159 billion […]
November 1, 2024
Nearly two thirds of patients with rheumatic conditions switched to medical cannabis from medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) and opioids, with the substitution being […]
November 1, 2024
TOPLINE: In patients with giant cell arteritis (GCA), intravenous methylprednisolone compared with oral glucocorticoids alone does not improve visual acuity and increases the risk for diabetes […]
November 1, 2024
TOPLINE: The use of newer biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) for treating juvenile idiopathic arthritis (JIA) rose sharply from 2001 to 2022, while […]
October 30, 2024
For people with severe symptomatic hip osteoarthritis, total hip replacement (THR) alleviates hip pain and improves function much more effectively than a resistance training program supervised […]
October 29, 2024
The European Alliance of Associations for Rheumatology (EULAR) is launching a new open-access journal — EULAR Rheumatology Open — in January 2025. The announcement is one of […]
October 28, 2024
TOPLINE: Allogeneic bone marrow–derived mesenchymal stromal cells (BM-MSCs) are safe but do not show efficacy in treating intervertebral disc degeneration (IDD) in patients with chronic low […]
October 28, 2024
TOPLINE: The extended-release fluticasone propionate injection (EP-104IAR) significantly reduces knee osteoarthritis (OA) pain over 12 weeks compared with a vehicle control, with no serious treatment-related adverse […]